LFMDLifeMD, Inc.

Nasdaq lifemd.com


$ 7.93 $ -0.20 (-2.4 %)    

Friday, 14-Jun-2024 15:59:59 EDT
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 7.92
$ 8.13
$ 0.00 x 0
$ 7.93 x 400
$ 7.90 - $ 8.13
$ 2.98 - $ 12.88
485,389
na
310.8M
$ -1.45
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-11-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-22-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-07-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-19-2020 03-31-2020 10-Q
18 03-30-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 04-01-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-17-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 04-02-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 07-07-2017 03-31-2017 10-Q
30 05-24-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-15-2016 06-30-2016 10-Q
33 05-16-2016 03-31-2016 10-Q
34 03-30-2016 12-31-2015 10-K
35 11-13-2015 09-30-2015 10-Q
36 08-13-2015 06-30-2015 10-Q
37 05-14-2015 03-31-2015 10-Q
38 03-30-2015 12-31-2014 10-K
39 11-14-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 keybanc-initiates-coverage-on-lifemd-with-overweight-rating-announces-price-target-of-12

Keybanc analyst Scott Schoenhaus initiates coverage on LifeMD (NASDAQ:LFMD) with a Overweight rating and announces Price Tar...

 lifemd-files-prospectus-related-to-resale-from-time-to-time-of-up-to-13m-shares-of-common-stock-held-by-selling-stockholders

- SEC Filing

 lifemd-to-join-russell-3000-index
LifeMD To Join Russell 3000 Index
05/29/2024 12:06:13

 b-riley-securities-reiterates-buy-on-lifemd-maintains-12-price-target

B. Riley Securities analyst William Woods reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $12 price target.

 hc-wainwright--co-reiterates-buy-on-lifemd-maintains-12-price-target

HC Wainwright & Co. analyst Yi Chen reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $12 price target.

 cantor-fitzgerald-maintains-overweight-on-lifemd-raises-price-target-to-15

Cantor Fitzgerald analyst Sarah James maintains LifeMD (NASDAQ:LFMD) with a Overweight and raises the price target from $13 ...

 lifemd-q1-2024-adj-eps-001-beats-015-estimate-sales-44144m-beat-42540m-estimate

LifeMD (NASDAQ:LFMD) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.15) by 106...

 lifemd-becomes-the-first-virtual-primary-care-provider-to-elevate-glp-1-patient-care-with-real-time-at-home-monitoring-of-blood-pressure-and-body-composition

LifeMD, Inc.® (NASDAQ:LFMD), a leading provider of virtual primary care services, and Withings Health Solutions, a leader in di...

 btig-maintains-buy-on-lifemd-raises-price-target-to-14

BTIG analyst David Larsen maintains LifeMD (NASDAQ:LFMD) with a Buy and raises the price target from $13 to $14.

 btig-maintains-buy-on-lifemd-raises-price-target-to-13

BTIG analyst David Larsen maintains LifeMD (NASDAQ:LFMD) with a Buy and raises the price target from $11 to $13.

 craig-hallum-maintains-buy-on-lifemd-raises-price-target-to-15

Craig-Hallum analyst Alex Fuhrman maintains LifeMD (NASDAQ:LFMD) with a Buy and raises the price target from $10 to $15.

 b-riley-securities-reiterates-buy-on-lifemd-raises-price-target-to-12

B. Riley Securities analyst William Woods reiterates LifeMD (NASDAQ:LFMD) with a Buy and raises the price target from $11 to...

 cantor-fitzgerald-maintains-overweight-on-lifemd-raises-price-target-to-11

Cantor Fitzgerald analyst Sarah James maintains LifeMD (NASDAQ:LFMD) with a Overweight and raises the price target from $9 t...